|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes |
IUPAC Name ![]() |
4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)-1,2-dihydrophthalazin-1-one |
International Nonproprietary Names ![]() |
|
INN number | INN |
4074 | azelastine |
Synonyms ![]() |
A-5610 | Astelin® | E-0659 | Rhinolast® | W-2979M |
Database Links ![]() |
|
CAS Registry No. | 58581-89-8 |
ChEMBL Ligand | CHEMBL639 |
DrugBank Ligand | DB00972 |
GtoPdb PubChem SID | 178103698 |
PubChem CID | 2267 |
Search Google for chemical match using the InChIKey | MBUVEWMHONZEQD-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | MBUVEWMHONZEQD |
Search PubMed clinical trials | azelastine |
Search PubMed titles | azelastine |
Search PubMed titles/abstracts | azelastine |
Search UniChem for chemical match using the InChIKey | MBUVEWMHONZEQD-UHFFFAOYSA-N |
Search UniChem for chemicals with the same backbone | MBUVEWMHONZEQD |
Wikipedia | Azelastine |
Comments |
There is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation. |